Skip to content

DOBi biobank: Biobank for Dutch Older Bipolar patients

DOBi biobank: Biobank for Dutch Older Bipolar patients - DOBi biobank

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44565
Enrollment
300
Registered
2018-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bipolar disorder manic-depressive

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients will be included in the study only if the diagnostic procedure (described next) ascertained a diagnosis of bipolar 1 disorder (DSM-IV-TR: 296.00- .06, 296.40-.46, 296.50-.56, 296.60-.66, 296.7), bipolar 2 disorder (DSM-IV-TR: 296.89), or bipolar disorder NOS (DSM-IV-TR: 296.80).

Exclusion criteria

Exclusion criteria: Patients unable to provide written informed consent due to inability to communicate in Dutch or English, mental retardation (defined as IQ below 70), poor cognition (Mini Mental State Examination (MMSE) below 18) or clinical diagnosis of dementia, or a highly unstable psychiatric condition (e.g. current compulsory admission) were excluded.

Design outcomes

Primary

MeasureTime frame
exploration of relation between pro-inflammatory cytokines (IL-6) and stage of bipolar disorder

Secondary

MeasureTime frame
none

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)